Most sold healthcare stocks in Q4 2023
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2023, measured as net reductions in reported share positions from Q3 2023 into Q4 2023. Notable reductions at the top of this list include OPTION CARE HEALTH INC (OPCH), ILLUMINA INC (ILMN), AGILON HEALTH INC (AGL), NOVARTIS AG-SPONSORED ADR (NVS). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| OPCH | OPTION CARE HEALTH INC | -5,882,934 | -$174.18M | 1 | 1 | 0 | 2 | 2 |
| ILMN | ILLUMINA INC | -4,680,183 | -$634.69M | 2 | 4 | 3 | 0 | 10 |
| AGL | AGILON HEALTH INC | -4,128,414 | -$77.10M | 1 | 1 | 2 | 0 | 4 |
| NVS | NOVARTIS AG-SPONSORED ADR | -2,803,653 | -$318.07M | 3 | 4 | 2 | 0 | 9 |
| WRBY | WARBY PARKER INC-CLASS A | -2,754,460 | -$34.43M | 0 | 2 | 1 | 0 | 3 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,300,207 | $124.57M | 1 | 4 | 2 | 0 | 10 |
| BDX | BECTON DICKINSON AND CO | -2,055,261 | -$718.08M | 2 | 5 | 5 | 1 | 15 |
| UNH | UNITEDHEALTH GROUP INC | -1,325,080 | -$443.83M | 5 | 10 | 18 | 1 | 37 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -1,217,813 | $212.49K | 0 | 1 | 0 | 1 | 1 |
| ARDX | ARDELYX INC | -1,185,273 | -$4.84K | 0 | 0 | 0 | 1 | 0 |
| OSCR | OSCAR HEALTH INC - CLASS A | -977,811 | $29.70M | 0 | 1 | 3 | 0 | 4 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -917,050 | $7.35M | 1 | 3 | 2 | 0 | 8 |
| ALLK | ALLAKOS INC | -835,748 | -$1.68K | 0 | 0 | 1 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | -827,081 | $300.27M | 3 | 3 | 10 | 0 | 16 |
| OPK | OPKO HEALTH INC | -808,643 | -$1.29K | 0 | 0 | 0 | 1 | 0 |
| OCGN | OCUGEN INC | -674,978 | -$226 | 0 | 0 | 1 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | -674,324 | $4.58M | 0 | 0 | 3 | 1 | 4 |
| PINC | PREMIER INC-CLASS A | -664,090 | -$13.30K | 0 | 0 | 1 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | -627,658 | -$26.97M | 0 | 2 | 1 | 1 | 3 |
| ZLAB | ZAI LAB LTD-ADR | -611,120 | -$9.16M | 1 | 1 | 1 | 0 | 4 |
| BBIO | BRIDGEBIO PHARMA INC | -584,146 | $351.68M | 0 | 0 | 0 | 1 | 1 |
| SGHT | SIGHT SCIENCES INC | -575,897 | -$1.98M | 0 | 1 | 0 | 1 | 1 |
| EXAS | EXACT SCIENCES CORP | -574,924 | $18.85M | 2 | 1 | 3 | 0 | 7 |
| TMO | THERMO FISHER SCIENTIFIC INC | -536,441 | $21.61M | 1 | 8 | 7 | 2 | 20 |
| IMUX | IMMUNIC INC | -502,594 | -$737 | 0 | 0 | 1 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | -483,732 | $285.22M | 1 | 1 | 6 | 1 | 9 |
| OFIX | ORTHOFIX MEDICAL INC | -464,572 | -$3.58M | 0 | 0 | 1 | 1 | 1 |
| MRNA | MODERNA INC | -453,741 | -$49.83M | 1 | 5 | 3 | 2 | 10 |
| PGEN | PRECIGEN INC | -442,987 | -$699 | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -408,688 | -$81.94M | 0 | 2 | 2 | 0 | 4 |
| HROW | HARROW INC | -339,878 | -$6.82K | 0 | 0 | 1 | 0 | 1 |
| ADMA | ADMA BIOLOGICS INC | -338,620 | -$218 | 0 | 0 | 1 | 0 | 1 |
| ALT | ALTIMMUNE INC | -330,600 | $2.52K | 1 | 0 | 0 | 1 | 1 |
| HCAT | HEALTH CATALYST INC | -309,913 | -$2.92M | 0 | 1 | 2 | 0 | 3 |
| DNLI | DENALI THERAPEUTICS INC | -305,905 | -$6.18K | 0 | 0 | 1 | 0 | 1 |
| CTKB | CYTEK BIOSCIENCES INC | -296,280 | $4.01K | 1 | 0 | 0 | 1 | 1 |
| TERN | TERNS PHARMACEUTICALS INC | -290,100 | -$1.46K | 0 | 0 | 0 | 1 | 0 |
| SNY | SANOFI-ADR | -263,360 | -$323.01M | 2 | 2 | 5 | 0 | 9 |
| EHAB | ENHABIT INC | -261,640 | -$2.94M | 0 | 0 | 0 | 2 | 0 |
| CDXS | CODEXIS INC | -260,286 | -$492 | 0 | 0 | 0 | 1 | 0 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | -258,105 | $64.63K | 0 | 1 | 1 | 1 | 2 |
| TGTX | TG THERAPEUTICS INC | -257,999 | $4.88M | 1 | 1 | 1 | 0 | 3 |
| GSK | GSK PLC-SPON ADR | -256,677 | $52.93M | 0 | 4 | 6 | 0 | 11 |
| LNTH | LANTHEUS HOLDINGS INC | -250,395 | -$132.38K | 0 | 2 | 0 | 1 | 2 |
| AUPH | AURINIA PHARMACEUTICALS INC | -249,102 | $3.11M | 1 | 0 | 3 | 0 | 4 |
| NARI | INARI MEDICAL INC | -246,846 | -$12.71K | 1 | 0 | 1 | 0 | 2 |
| ABCL | ABCELLERA BIOLOGICS INC | -232,550 | $551 | 0 | 0 | 1 | 0 | 1 |
| VYGR | VOYAGER THERAPEUTICS INC | -220,500 | -$1.58K | 0 | 0 | 1 | 0 | 1 |
| SNDX | SYNDAX PHARMACEUTICALS INC | -218,300 | -$3.17K | 0 | 0 | 0 | 1 | 0 |
| PIII | P3 HEALTH PARTNERS INC | -210,785 | -$319 | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2023
What are the most sold Healthcare stocks in Q4 2023?
The most sold healthcare stocks in Q4 2023 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2023?
Among filers in this sector, net reductions were largest in companies such as OPTION CARE HEALTH INC (OPCH), ILLUMINA INC (ILMN), AGILON HEALTH INC (AGL), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.